Latest debt-to-equity ratio
ADARx Pharmaceuticals Debt-to-equity ratio
Direct answer
ADARx Pharmaceuticals's debt-to-equity ratio is 6.47%.
The verified market snapshot reports 6.47%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 10, 2026.
Get free ADARx Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 6.47%
Explore related company data
View ADARx Pharmaceuticals's market capitalizationView ADARx Pharmaceuticals's dividend yieldView ADARx Pharmaceuticals's 52-week price rangeView ADARx Pharmaceuticals's revenue growthView ADARx Pharmaceuticals's profit marginView all ADARx Pharmaceuticals key metricsReturn to ADARx Pharmaceuticals profile